Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 10, 2005, Pages 1222-1225

  Wörker, Stefan ^a   Bartsch, Rupert ^a   Hejna, Michael ^a   Drach, Johannes ^a   Raderer, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chemotherapy; Gastric lymphoma; Pantoprazole; Proton pump inhibitors

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METRONIDAZOLE; MITOXANTRONE; PANTOPRAZOLE; PREDNISONE; PROTON PUMP INHIBITOR; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER REGRESSION; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG RESPONSE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; REMISSION; STOMACH LYMPHOMA; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZIMIDAZOLES; CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MIDDLE AGED; MITOXANTRONE; NEOPLASM STAGING; OMEPRAZOLE; PATIENT COMPLIANCE; PREDNISONE; PROTON PUMPS; STOMACH NEOPLASMS; SULFOXIDES; TREATMENT OUTCOME; VINCRISTINE;

EID: 27144490020     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520510023440     Document Type: Article

References (18)

1. Isaacson PG. Primary gastric lymphoma. Br J Biomed Sci 1995;52:291-6.
2. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727-37.
3. Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol 1999;10:1023-33.
4. Severson RK, Davis S. Increasing incidence of primary gastric lymphoma. Cancer 1990;66:1283-7.
5. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma: results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001;19:3874-83.
6. Raderer M, Isaacson PG. Extranodal lymphoma of MALT-type: perspective at the beginning of the 21st century. Expert Rev Anticancer Ther 2001;1:53-64.
7. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000;96:410-9.
8. Aviles A, Nambo MJ, Neri N, Huerta-Guzman J, Cuadra I, Alvarado I, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg 2004;240:44-50.
9. Binn M, Ruskone-Fourmestraux A, Lepage E, Haioun C, Delmer A, Aegerter P, et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol 2003;14:1751-7.
10. Maisey N, Norman A, Prior Y, Cunningham D. Chemotherapy for primary gastric lymphoma: does in-patient observation prevent complications? Clin Oncol (R Coll Radiol) 2004;16:48-52.
11. WHO. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909-18.
12. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas [author's transl]. Strahlentherapie 1977;153: 218-21.
13. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992;102:1628-38.
14. Raderer M, Chott A, Drach J, Montalban C, Dragosics B, Jager U, et al. Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Ann Oncol 2002;13:1094-8.
15. Wohrer S, Puspok A, Drach J, Hejna M, Chott A, Raderer M. Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Ann Oncol 2004;15: 1086-90.
16. Jager G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 2002;20: 3872-7.
17. Wohrer S, Drach J, Hejna M, Scheithauer W, Dirisamer A, Puspok A, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol 2003;14:1758-61.
18. Sachs G. Physiology of the parietal cell and therapeutic implications. Pharmacotherapy 2003;23:68S-73S.